Advertisement
ProteinSimple
ProteinSimple

The Scientist

» drug development

Most Recent

image: FDA to Revamp Rare Disease Efforts

FDA to Revamp Rare Disease Efforts

By | September 12, 2011

The US government agency vows to improve the way it facilitates the development and approval of drugs for orphan diseases.

3 Comments

image: Detecting New Synthetic Drugs

Detecting New Synthetic Drugs

By | September 1, 2011

Forensic labs in the United States should be better equipped to identify a new crop of recreational drug mimics.

0 Comments

image: Data-Mining for New Treatments

Data-Mining for New Treatments

By | August 18, 2011

A new database helps scientist predict new uses for existing drugs.

3 Comments

image: FDA's Biomarker and Device Advice

FDA's Biomarker and Device Advice

By | August 18, 2011

The US federal agency issues draft rules to guide medical device makers and those hoping to register biomarkers.

0 Comments

image: Facebook Forces Pharma to Show Comments

Facebook Forces Pharma to Show Comments

By | August 17, 2011

The social media site enforces its rule that pages should allow social interaction through comments, even on drug company pages.

0 Comments

image: The Father of Trial Randomization Dies

The Father of Trial Randomization Dies

By | August 15, 2011

Statistician Paul Meier, who championed the random assignment of patients to treatment groups in clinical trials, changed the way the researchers test experimental drugs.

0 Comments

image: FDA Discusses Biosimilars

FDA Discusses Biosimilars

By | August 8, 2011

The government says regulatory requirements for generic biological therapies will have to be tailored to the treatment in question.

3 Comments

image: Battling Malaria in Africa

Battling Malaria in Africa

By | August 1, 2011

When general practitioner John Lusingu returned to his native Tanzania to do research on malaria, he was met with a total lack of science infrastructure. 

0 Comments

image: CRO Fakes Research

CRO Fakes Research

By | July 28, 2011

FDA points its finger at an early-stage contract research organization for falsifying documents and manipulating samples.

0 Comments

image: Patents Expire for Big Name Drugs

Patents Expire for Big Name Drugs

By | July 25, 2011

As seven of the world’s top selling drugs expire over the next year, prescription prices are set to drop while generics fill in.

6 Comments

Follow The Scientist

icon-facebook icon-linkedin icon-twitter icon-vimeo icon-youtube
Advertisement
QIAGEN Ingenuity
QIAGEN Ingenuity

Stay Connected with The Scientist

  • icon-facebook The Scientist Magazine
  • icon-facebook The Scientist Careers
  • icon-facebook Neuroscience Research Techniques
  • icon-facebook Genetic Research Techniques
  • icon-facebook Cell Biology Research
  • icon-facebook Microbiology and Immunology
  • icon-facebook Cancer Research and Technology
  • icon-facebook Stem Cell and Regenerative Science
Advertisement
Advertisement